Published Date: 31-May-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Renal Denervation Market size is expected to reach $1.4 billion by 2028, rising at a Market growth of 36.4% CAGR during the forecast period.
The Radiofrequency segment acquired maximum revenue share in the Global Renal Denervation Market by Technology in 2021, thereby, achieving a Market value of $774.6 million by 2028. In the renal denervation Market , radiofrequency was the most commonly utilized technique in various healthcare facilities all over the world. Radiofrequency renal denervation is a successful treatment for resistant hypertension, with a single procedure lowering blood pressure for up to two years. Due to the efficient and more long-lasting effect of this method, the growth of this segment is anticipated to surge over the forecast period.
The Specialty Clinics segment is showcasing a CAGR of 37% during (2022 - 2028). The rising growth of this segment is owing to the increasing accessibility of people all over the world to specialty clinics. Ear, Nose, and Throat, Rheumatology, Allergy and Immunology, Dermatology, Orthopedics, Cardiology, Allergy & Pulmonary, Women's Health, Urology, Obstetrics/Gynecology, Podiatry, and General Surgery are among the specialties offered by the Specialty Clinic. Therefore, the growth of the segment would be substantially expedited.
The Enlightn Market is expected to witness a CAGR of 37.1% during (2022 - 2028). The increasing growth of the segment is owing to the safety and effectiveness of this product type. In addition, this is the first multi-electrode ablation technology, which offers a pre-determined ablation set in a single positioning. This factor is accelerating the growth of this segment of the Market .
The North America is the fastest growing region in the Global Renal Denervation Market by Region in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $513.9 million by 2028. The Europe Market is estimated to witness a CAGR of 35.5% during (2022 - 2028). Additionally, The Asia Pacific Market would exhibit a CAGR of 38.8% during (2022 - 2028).
The Market research report has exhaustive quantitative insights providing a clear picture of the Market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the Market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Ablative Solutions, Inc., Mercator MedSystems, Inc., ReCor Medical, Inc., Renal Dynamics Limited, Johnson & Johnson, and Terumo Corporation.
By End User
By Product Type
Unique Offerings from KBV Research